Clinical Trial Update: A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma [Phase 2]

View source ↗

Summary

This notice reports the completion of a Phase II trial evaluating leuprolide, flutamide, and suramin in untreated poor-prognosis prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprolide (Leuprolide acetate)
• Suramin (suramin)
• flutamide (flutamide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasm | Phase 2 | Status: COMPLETED